Frunevetmab, a felinized anti‐nerve growth factor monoclonal antibody, for the treatment of pain from osteoarthritis in cats

BACKGROUND: Frunevetmab, a felinized antinerve growth factor monoclonal antibody, effectively decreases osteoarthritis (OA) pain in cats. OBJECTIVE: To evaluate the efficacy of frunevetmab given at monthly intervals in a randomized, placebo‐controlled, parallel‐group, double‐blind superiority study....

Descripción completa

Detalles Bibliográficos
Autores principales: Gruen, Margaret E., Myers, Jamie A. E., Tena, Jezaniah‐Kira S., Becskei, Csilla, Cleaver, Dawn M., Lascelles, B. Duncan X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692178/
https://www.ncbi.nlm.nih.gov/pubmed/34724255
http://dx.doi.org/10.1111/jvim.16291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692178/
https://www.ncbi.nlm.nih.gov/pubmed/34724255
http://dx.doi.org/10.1111/jvim.16291

Ejemplares similares